SARS-CoV-2 variants rapidly arise in non-human hosts, potential risk for human reinfection
The coronavirus disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),...
Researchers report zoonotic spillover of adapted SARS-CoV-2 from minks to humans
In a recent report made available on bioRxiv* prep...
New academic spin-out based in Finland introduces a nasal spray vaccine against COVID
Rokote Laboratories Finland Ltd., a newly-founded ...
SARS-CoV-2 escapes host immune responses by modulating dendritic cell maturation
A team of scientists from Italy and the USA has re...
Poll: Americans largely back Biden’s virus response
Joe Biden is enjoying an early presidential honeym...
Cell surface marker CD47 may allow early diagnosis of severe COVID-19
One of the most disturbing things about the ongoin...
Fauci presents his personal virus model to Smithsonian
Dr. Anthony Fauci, the face of the U.S. government...
Survey reveals impact of Pfizer-BioNTech vaccination in the UK
Researchers at Imperial College London in the UK h...
Successful SARS-CoV-2 vaccination hinges on non-pharmaceutical interventions and vaccine deployment strategies
The accelerated rate of vaccine development agains...
Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19
A rapid spread of the virus that caused symptoms s...